Clinical Trial Update: Study of the Orsiro Drug Eluting Stent System [NA]

View source ↗

Summary

Clinical trial update for the Orsiro Drug Eluting Stent System in coronary artery disease, sponsored by Biotronik AG, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Orsiro Drug Eluting Stent System

Snippet

Sponsor: Biotronik AG | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN